Angewandte
Chemie
synthesis of 1a.[6b] In contrast to ApPDC, PfBAL provides
a large donor-binding site, which is ideal for stabilizing
benzaldehyde in that position. However, owing to a missing S-
pocket, PfBAL only allows the parallel arrangement of the
donor and acceptor benzaldehydes prior to carboligation.
Furthermore, S-pocket engineering is limited in PfBAL by
the position of the protein backbone of the respective a-helix
in the S-pocket region (Figure 1B).
To solve the long-standing problem of enzymatic (S)-
benzoin synthesis, a rational hybridization approach was
followed, in which the active-site characteristics of the variant
ApPDC-E469G[7] and PfBAL were combined. Two
approaches were conceivable: 1) the introduction of a large
S-pocket into PfBAL, or 2) the extension of the donor-
binding site of ApPDC-E469G. Herein, we show that the
second approach indeed resulted in the first tailor-made S-
selective ThDP-dependent enzyme variant for the formation
of various benzoins.
A combination of modeling studies and a comprehensive
sequence analysis of the amino acid distribution in 186
homologous PDC sequences and 43 BAL sequences led to the
identification of a threonine residue (T384) as the pivotal
factor that influences the size of the donor-binding site in
ApPDC-E469G. T384 limits the space for benzaldehyde in the
donor-binding site and is conserved in 92% of ApPDC
homologous sequences (Figure 2A), whereas glycine was
found at the equivalent position in all PfBAL homologous
sequences. T384 in ApPDC-E469G was replaced with glycine
through site-directed mutagenesis in order to mimic the
PfBAL donor-binding site. As a result, an enlarged donor-
binding site with putatively sufficient space for benzaldehyde
was obtained (Figure 2B). Moreover, short molecular dynam-
ics simulations revealed that a neighboring tryptophan
residue (W388) underwent minor conformational changes,
probably because of interactions with the ThDP-bound
benzaldehyde donor (hydroxybenzyl), thereby further open-
ing up the donor-binding site.
Biochemical characterization of the new variant proved
that the single mutation of T384 to glycine indeed altered the
chemoselectivity of ApPDC-E469G, which subsequently
preferred benzaldehyde as the donor. Whereas no significant
formation of 1a in the homocoupling of benzaldehyde was
observed with ApPDC-E469G (Table 1, entry 1), double
Table 1: Enzymatic synthesis of (S)-1a as catalyzed by ApPDC variants.[a]
Entry
ApPDC variant
ee [%][b]
Conv. [%][c]
1
2
3
4
5
6
E469G
E469G/T384G
E469G/T384G/I468G
E469G/T384G/I468A
E469G/T384G/I468V
E469G/T384G/I468V/W543F
n.d.[d]
59
66
87
76
<1
52
23
95
40
36
95
[a] Reaction conditions: 50 mm triethanolamine buffer, pH 8.0, 2 mm
MgSO4, and 0.1 mm ThDP; 1 mgmLÀ1 enzyme; 18 mm benzaldehyde;
208C, 6 h; [b] determined by chiral-phase HPLC; [c] Determined by
chiral-phase HPLC based on the consumption of benzaldehyde; [d] Not
determined.
variant ApPDC-E469G/T384G catalyzed the benzoin forma-
tion with 52% conversion under the tested conditions
(entry 2). The preference for benzaldehyde as the donor
was also demonstrated in the mixed carboligation of acetal-
dehyde and benzaldehyde by variant ApPDC-E469G/T384G,
which resulted in the formation of a mixture of 1a and 2-
hydroxypropiophenone (2-HPP), whereas PAC, the main
product obtained with wild-type ApPDC or variant ApPDC-
E469G,[7] was only detected in trace amounts. Furthermore,
variant ApPDC-E469G/T384G catalyzed both the synthesis
of (S)-1a from benzaldehyde with moderate stereoselectivity
(59% ee, entry 2) and mixed carboligation towards 2-HPP
with good S-selectivity (91% ee).
To improve the moderate S-selectivity of ApPDC-E469G/
T384G, two strategies are possible: stabilization of the
antiparallel (“S-pathway”) or destabilization of the parallel
acceptor orientation (“R-pathway”) prior to carboligation.[8]
To suppress the R-pathway in ApPDC-E469G/T384G, the
active site was examined for residues that potentially stabilize
the acceptor benzaldehyde in the parallel orientation. By
performing molecular modeling, I468 and W543 were iden-
tified (Figure 3A) as residues that could stabilize parallel-
oriented benzaldehyde through nonpolar interactions or p-
stacking.
I468 was replaced with valine, glycine, or alanine to
increase the distance of the respective side chain to parallel-
oriented benzaldehyde and thus disrupt the stabilization of
the R-pathway (Figure 3B). In all cases, the new variants
showed improved S-selectivity for the formation of (S)-1a
(Table 1, entries 3–5). Out of the different variants, the triple
variant E469G/T384G/I468A performed best with respect to
ee (87%, S) and conversion (95%) under standard reaction
conditions. The high conversion is particularly surprising
Figure 2. Stereoview of the donor-binding sites of ApPDC-E469G (A)
and ApPDC-E469G/T384G (B) with benzaldehyde bound as a hydrox-
ybenzyl group (gray) to C2 of ThDP (orange). A) ApPDC-E469G is not
able to properly bind benzaldehyde in the small donor-binding site,
which is mainly restricted by T384 (red). B) The donor-binding site
could be opened for benzaldehyde by replacing T384 with glycine.
Moreover, the equilibrated structure revealed conformational changes
to W388 (green) that additionally opened the donor-binding site.
Angew. Chem. Int. Ed. 2014, 53, 9376 –9379
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9377